Top Banner
The Strain Problem Taylor Goldbeck
15

Taylor Goldbeck. Professor and Head of Neuropathology at Yale- Department of Surgery and Faculty of Neurosciences and Virology Focuses on dementia.

Jan 14, 2016

Download

Documents

Blaise Paul
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Taylor Goldbeck.  Professor and Head of Neuropathology at Yale- Department of Surgery and Faculty of Neurosciences and Virology  Focuses on dementia.

The Strain ProblemTaylor Goldbeck

Page 2: Taylor Goldbeck.  Professor and Head of Neuropathology at Yale- Department of Surgery and Faculty of Neurosciences and Virology  Focuses on dementia.

Laura Manuelidis- Who is she? Professor and Head of

Neuropathology at Yale- Department of Surgery and Faculty of Neurosciences and Virology

Focuses on dementia was emphasis on TSEs

“We think it is most likely the host PrP is a required receptor for TSE viruses, and that viral PrP-membrane interactions ultimately cause a pathological PrP response. Ongoing experiments are designed to test this viral hypothesis”

Page 3: Taylor Goldbeck.  Professor and Head of Neuropathology at Yale- Department of Surgery and Faculty of Neurosciences and Virology  Focuses on dementia.
Page 4: Taylor Goldbeck.  Professor and Head of Neuropathology at Yale- Department of Surgery and Faculty of Neurosciences and Virology  Focuses on dementia.

How do viral strains occur?

Page 5: Taylor Goldbeck.  Professor and Head of Neuropathology at Yale- Department of Surgery and Faculty of Neurosciences and Virology  Focuses on dementia.

Prion strain- defined as “infectious isolates that, when transmitted to identical hosts, exhibit distinct prion-disease phenotypes”

Prion strain diversity first seen in goats PrP-c and PrP-sc can be unglycosylated,

monoglycosylated or diglycosylated.

Prion Strains

Aguzzi, A., Heikenwalder, M., Polymenidou, M. (2007). Insights into prion strains and neurotoxicity. Nature. 8:552-561

Page 6: Taylor Goldbeck.  Professor and Head of Neuropathology at Yale- Department of Surgery and Faculty of Neurosciences and Virology  Focuses on dementia.

Aguzzi et al. (2007). Insights into prion strains and neurotoxicity. Nature.8): 552-561

Page 7: Taylor Goldbeck.  Professor and Head of Neuropathology at Yale- Department of Surgery and Faculty of Neurosciences and Virology  Focuses on dementia.

PrP-res ◦ Part of response, not the cause◦ Host protein

“(i) The variety of unique and mutable agent strains, a property of nuclei acid not protein”◦ Initial thoughts on this point?

High CJD Infectivity Remains After Prion Protein is Destroyed

Page 8: Taylor Goldbeck.  Professor and Head of Neuropathology at Yale- Department of Surgery and Faculty of Neurosciences and Virology  Focuses on dementia.

Manuelidis et al (1997) Argue:

◦ Several strains, same PrP amino acid sequence◦ Different phenotypes

Due to PrP protein or hidden virus? Experiment

◦ Change a CJD strain into a strain that produced plaques and cerebellar lesions Evaluated host recognition by responses of microglia

and astrocytes Used inbred mice, guinea pigs, and rats.

2/6 rats showed a response after first passageManueldis, L., Fritch, W., Xi, Y. (1997). Evolution of a strain of CJD that Induces

BSE-Like Plaques. Science. 277(5322): 94-98.

Evidence for Viral Genome

Page 9: Taylor Goldbeck.  Professor and Head of Neuropathology at Yale- Department of Surgery and Faculty of Neurosciences and Virology  Focuses on dementia.
Page 10: Taylor Goldbeck.  Professor and Head of Neuropathology at Yale- Department of Surgery and Faculty of Neurosciences and Virology  Focuses on dementia.

If you were pro protein-only hypothesis, how would you explain the reactive microglia and astrocytes?

Authors state “Species barrier and host responses (reactive microglia, astrocytes, and development of new strain that can produce plaques/lesions from a strain that couldn’t before) to the foreign agent are too complex to just be explained by the host’s PrP sequence”◦ If you were pro protein-only hypothesis, how would

you respond to this?

Your Thoughts-

Page 11: Taylor Goldbeck.  Professor and Head of Neuropathology at Yale- Department of Surgery and Faculty of Neurosciences and Virology  Focuses on dementia.

“TSE strains maintain their identity despite various changes in prion protein. This fact strongly implicates a relatively stable but mutable viral genome” (from Yale bio page)

Wanted to see whether PrP-res itself encoded intrinsic infectivity characteristics

Slow SY strain and fast virulent FU CJD strain infect GT1 cells into various cell lines◦ Kept phenotypes through passage but remained indistinguishable by

PrP-res banding or glycosylation patterns FU had different PrP-res patterns in different cell lines

Still had same incubation time and clinical features

◦ Amount of PrP-res was not quantitatively related to infectivity “It is the biology of these agents: their evolution spread, cell

specificity, latency, virus-like interference capabilities and occusional mutation which continues to indicate a viral causative agent”

◦ Arjona et al. (2004). Two Creutzfeldt-Jakob disease agents reproduce prion protein-independent identities in cell cultures. PNAS. 101(23): 8768-8773

Evidence for Viral Genome

Page 12: Taylor Goldbeck.  Professor and Head of Neuropathology at Yale- Department of Surgery and Faculty of Neurosciences and Virology  Focuses on dementia.

Authors argue “These findings (two strains that have different phenotypes but same PrP-res banding or glycosylation patterns) are problematic for the prion hypothesis where abnormal PrP folding or glycosylation, and hense PrP-res band patterns, are postulated to encode each agent strain”◦ If you were pro- protein-only hypothesis, how

would you respond?

Your Thoughts-

Page 13: Taylor Goldbeck.  Professor and Head of Neuropathology at Yale- Department of Surgery and Faculty of Neurosciences and Virology  Focuses on dementia.

Methods: Exposed cells to various dilutions of prion samples, let the cells propagate, determined the proportion of PrP-sc containing cells by ELISA◦ Strain 22L transferred from brain to PK1 cells ◦ In the presence of swainsonine, 22L-infected PK1 cells

led to drug-resistant variants◦ 22L prions transferred to R33 cell population◦ R33 incompetent/swa-sensitive cells return to brain

Mahal et at. (2010). Transfer of a prion strain to different hosts leads to emergence of

strain variants. PNAS. 107(52): 22653-22658

Evidence for prion protein-only hypothesis

Page 14: Taylor Goldbeck.  Professor and Head of Neuropathology at Yale- Department of Surgery and Faculty of Neurosciences and Virology  Focuses on dementia.

Showed prions can adapt to survive in a new host environment ◦ When transferring from one cell line to another,

prion properties chance “Darwinian Evolution without DNA”

◦ Prions can develop mutations drug resistance ◦ Fold in different ways new strains◦ Transferred to a new host which strain ‘wins’?

Your thoughts◦ If you were Manulidis, how would you respond to

this paper?

“The fact that they behave like viruses doesn’t mean they’re anything like a virus”- Weissman

(coauthor)

Page 15: Taylor Goldbeck.  Professor and Head of Neuropathology at Yale- Department of Surgery and Faculty of Neurosciences and Virology  Focuses on dementia.

Back to PrP glycosylation◦ Study by Cancellotti et al., (2013) showed that the passage of

mice that expressed a PrP that either partially or completely lacked N-glycan affected the phenotypic characteristics of at least one TSE strain

Back to species barrier◦ Quasispecies hypothesis

Several PrP-sc conformations in infectious innoculum. One best suited for new host is selected for Problem- there isn’t a lot of evidence that a large number of

conformations exists in an innoculum Another problem?

Explaining the relationship between PrP-res and infectivity

Poggiolini, I., Saverloni, D., Parchi, P. (2013). Prion Protein Misfolding, Strains, and Neurotoxicity: An Update from Studies on Mammalian Prions. International Journal of Cellular Biology. 1-24

Soto, C and Castilla, J. (2004). The controversial protein-only hypothesis of prion propagation. Nature medicine. 563-567

Other evidence for prion protein-only hypothesis